TY  - GEN
AU  - Chan,Andrew T
AU  - Zauber,Ann G
AU  - Hsu,Meier
AU  - Breazna,Aurora
AU  - Hunter,David J
AU  - Rosenstein,Rebecca B
AU  - Eagle,Craig J
AU  - Hawk,Ernest T
AU  - Bertagnolli,Monica M
TI  - Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma
SN  - 1528-0012
PY  - 2009///0708
KW  - Adenoma
KW  - drug therapy
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Aryl Hydrocarbon Hydroxylases
KW  - drug effects
KW  - Celecoxib
KW  - Colorectal Neoplasms
KW  - Confidence Intervals
KW  - Cytochrome P-450 CYP2C9
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Follow-Up Studies
KW  - Genetic Predisposition to Disease
KW  - Genetic Variation
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Pharmacogenetics
KW  - Probability
KW  - Pyrazoles
KW  - therapeutic use
KW  - Reference Values
KW  - Risk Assessment
KW  - Sensitivity and Specificity
KW  - Sulfonamides
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1053/j.gastro.2009.02.045
ER  -